Arquer Diagnostics
@ArquerDx
#ADXBLADDER is available free of charge for #urologists that work for the #NHS and can be obtained by calling us on 0191 576 6755. Those with private #patients can also obtain a #test by emailing adxbladder@synlab.co.uk today. https://t.co/J2iphSc9HZ 
Arquer Diagnostics
@ArquerDx
#COVID19 has prevented the testing of > 18k people referred to an Urologist for suspected #bladdercancer.
#ADXBLADDER, a simple urine test, is available for private patients who don’t want to wait any longer.
For private testing Urologists can email: adxbladder@synlab.co.uk
Arquer Diagnostics
@ArquerDx
We are offering #NHS hospitals thousands of our #ADXBLADDER tests for free to help #Urologists quickly assess patients with suspected #bladdercancer.
Helping you clear the #cancerbacklog
https://t.co/Qk7sgCDjTD https://t.co/MMkvWWzoQL 
Arquer Diagnostics
@ArquerDx
At least 18,000 people already referred to a hospital urologist for suspected #bladdercancer have not been tested due to #COVID19.
#ADXBLADDER, a simple, rapid, urine test is now available for NHS patients.
Don’t wait. Ask your doctor, today.
https://t.co/ZlQ4367QpP https://t.co/3TWuX85X8U 
Arquer Diagnostics Announces Exclusive Agreement with SYNLAB to Accelerate the Introduction in the UK of Game-Changing non-invasive Diagnostic test for Patients with Suspected Bladder Cancer
Sunderland, United Kingdom, 13th July 2020 – Arquer Diagnostics, a UK-based company committed to manufacturing and marketing innovative, non-invasive tests for diagnosing and monitoring cancer, today announced that it has entered into an exclusive agreement with SYNLAB UK & Ireland, a leading medical diagnostic services provider.